Phase 1
LAI287 (NN1436)
Diabetes
PI406 (NN1406)
Diabetes
PYY 1562 (NN9748)
Diabetes
AM833 (NN9838)
Obesity & Other areas
G530S (NN9030)
Obesity & Other areas
PYY 1562 (NN9747)
Obesity & Other areas
GG-co-agonist 1177 (NN9277)
Obesity & Other areas
FGF21 Obesity (NN9499)
Obesity & Other areas
Tri-agonist 1706 (NN9423)
Obesity & Other areas
Concizumab (NN7415)
Haemophilia
Subcutaneous N8-GP (NN7170)
Haemophilia
Phase 2
Anti-IL 21 GLP-1 T1D (NN9828)
Diabetes
Semaglutide Obesity (NN9536)
Obesity & Other areas
Semaglutide NASH (9931)
Obesity & Other areas
Phase 3
Oral semaglutide (NN9924)
Diabetes
N8-GP (NN7088)
Haemophilia
Somapacitan (NN8640)
Growth Disorders
Filed
Fast acting insulin aspart (NN1218)
Diabetes
Semaglutide (NN9535)
Diabetes
N9-GP (NN7999)
Haemophilia
